Serum fetuin-A and vitamin D in children with mild-to-severe chronic kidney disease: A cross-sectional study

Nephrology Dialysis Transplantation

Volumn 27, Issue 3, 2012, Pages 1107-1113

  Schaible, Jan ^a   Wigger, Marianne ^a   Staude, Hagen ^a   Drueckler, Erdmute ^a   Kundt, Guenther ^a   Haffner, Dieter ^a,b   Fischer, Dagmar Christiane ^a,b  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Children; Chronic kidney disease; Fetuin A; Treatment; Vitamin D

Indexed keywords

C REACTIVE PROTEIN; CALCIFEDIOL; CALCITRIOL; FETUIN A; PARATHYROID HORMONE;

ADOLESCENT; ARTICLE; CHILD; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

ADOLESCENT; ALPHA-2-HS-GLYCOPROTEIN; C-REACTIVE PROTEIN; CALCITRIOL; CALCIUM; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; PARATHYROID HORMONE; RENAL DIALYSIS; RENAL REPLACEMENT THERAPY; VITAMIN D;

EID: 84861121454     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr382     Document Type: Article

References (37)

1. Lebreton JP, Joisel F, Raoult JP et al. Serum concentration of human alpha 2 HS glycoprotein during the inflammatory process: evidence that alpha 2 HS glycoprotein is a negative acute-phase reactant. J Clin Invest 1979; 64: 1118-1129
2. Denecke B, Graber S, Schafer C et al. Tissue distribution and activity testing suggest a similar but not identical function of fetuin-B and fetuin-A. Biochem J 2003; 376: 135-145
3. Jahnen-Dechent W, Schäfer C, KettelerMet al. Mineral chaperones: a role for fetuin-A and osteopontin in the inhibition and regression of pathologic calcification. J Mol Med 2008; 86: 379-389
4. Lee C, Bongcam-Rudloff E, Sollner C et al. Type 3 cystatins; fetuins, kininogen and histidine-rich glycoprotein. Front Biosci 2009; 14: 2911-2922
5. Ix JH, Wassel CL, Kanaya AM et al. Fetuin-A and incident diabetes mellitus in older persons. JAMA 2008; 300: 182-188
6. Ix JH, Shlipak MG, Brandenburg VM et al. Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study. Circulation 2006; 113: 1760-1767
7. Weikert C, Stefan N, Schulze MB et al. Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke. Circulation 2008; 118: 2555-2562
8. Ketteler M, Bongartz P, Westenfeld R et al. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 2003; 361: 827-833
9. Hermans MM, Brandenburg V, KettelerMet al. Association of serum fetuin-A levels with mortality in dialysis patients. Kidney Int 2007; 72: 202-207
10. Stenvinkel P, Wang K, Qureshi AR et al. Low fetuin-A levels are associated with cardiovascular death: impact of variations in the gene encoding fetuin. Kidney Int 2005; 67: 2383-2392
11. Moe SM, Reslerova M, Ketteler M et al. Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD). Kidney Int 2005; 67: 2295-2304
12. Wang AY, Woo J, Lam CW et al. Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients. Nephrol Dial Transplant 2005; 20: 1676-1685
13. Kis E, Cseprekal O, Biro E et al. Effects of bone and mineral metabolism on arterial elasticity in chronic renal failure. Pediatr Nephrol 2009; 24: 2413-2420
14. Ziolkowska H, Brzewski M, Roszkowska-Blaim M. Determinants of the intima-media thickness in children and adolescents with chronic kidney disease. Pediatr Nephrol 2008; 23: 805-811
15. Shroff RC, Shah V, Hiorns MP et al. The circulating calcification inhibitors, fetuin-A and osteoprotegerin, but not Matrix Gla protein, are associated with vascular stiffness and calcification in children on dialysis. Nephrol Dial Transplant 2008; 23: 3263-3271
16. Shroff R, Egerton M, BridelMet al. A bimodal association of vitamin D levels and vascular disease in children on dialysis. J Am Soc Nephrol 2008; 19: 1239-1246
17. Mehrotra R, Westenfeld R, Christenson P et al. Serum fetuin-A in nondialyzed patients with diabetic nephropathy: relationship with coronary artery calcification. Kidney Int 2005; 67: 1070-1077
18. Manenti L, Vaglio A, Pasquali S. Increased fetuin-A levels following treatment with a vitamin D analog. Kidney Int 2010; 78: 1187, author reply 1187-1189
19. K/DOQI. Clinical practice guidelines for bone metabolism and disease in children with chronic kidney disease. Am J Kidney Dis 2005; 46: S1-S103
20. Wigger M, Schaible J, Muscheites J et al. Fetuin-A serum concentrations in healthy children. Ann Clin Biochem 2009; 46: 511-513
21. Kromeyer-Hauschild K, Wabitsch M, Kunze D et al. Percentiles of body mass index in children and adolescents evaluated from different regional German studies. Monatsschr Kinderh 2001; 14: 807-818
22. Prader A, Largo RH, Molinari L et al. Physical growth of Swiss children from birth to 20 years of age. First Zurich longitudinal study of growth and development. Helv Paediatr Acta Suppl 1989; 52: 1-125
23. Schwartz GJ, Brion LP, Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 1987; 34: 571-590
24. Hogg RJ, Furth S, Lemley KV et al. National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification. Pediatrics 2003; 111: 1416-1421
25. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266-281
26. Plum LA, DeLuca HF. Vitamin D, disease and therapeutic opportunities. Nat Rev Drug Discov 2010; 9: 941-955
27. Verstuyf A, Carmeliet G, Bouillon R et al. Vitamin D: a pleiotropic hormone. Kidney Int 2010; 78: 140-145
28. Querfeld U, Mak RH. Vitamin D deficiency and toxicity in chronic kidney disease: in search of the therapeutic window. Pediatr Nephrol 2010; 25: 2413-2430
29. Bouillon R, Carmeliet G, Verlinden L et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 2008; 29: 726-776
30. Andrade MC, Carvalhaes JT, Carvalho AB et al. Bone mineral density and bone histomorphometry in children on long-term dialysis. Pediatr Nephrol 2007; 22: 1767-1772
31. Martin KJ, Gonzalez EA. Vitamin D analogues for the management of secondary hyperparathyroidism. Am J Kidney Dis 2001; 38: S34-S40
32. Sanchez CP, Salusky IB. The renal bone diseases in children treated with dialysis. Adv Ren Replace Ther 1996; 3: 14-23
33. Hausler M, Schafer C, Osterwinter C et al. The physiologic development of fetuin-a serum concentrations in children. Pediatr Res 2009; 66: 660-664
34. Cottone S, Palermo A, Arsena R et al. Relationship of fetuin-A with glomerular filtration rate and endothelial dysfunction in moderatesevere chronic kidney disease. J Nephrol 2010; 23: 62-69
35. Manghat P, Souleimanova I, Cheung J et al. Association of bone turnover markers and arterial stiffness in pre-dialysis chronic kidney disease (CKD). Bone 2011; 48: 1127-1132
36. Smith ER, Ford ML, Tomlinson LA et al. Poor agreement between commercial ELISAs for plasma fetuin-A: an effect of protein glycosylation? Clin Chim Acta 2010; 411: 1367-1370
37. Hamano T, Matsui I, Mikami S et al. Fetuin-mineral complex reflects extraosseous calcification stress in CKD. J Am Soc Nephrol 2010; 21: 1998-2007